+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 80Years
All Genders
Healthy Volunteers
ID04655235

Study of Brain Chemical Activity and Genetics in Schizophrenia Using EEG, fMRI, and Blood Tests

Led by RWTH Aachen University · Updated on 2025-03-14

600

Participants Needed

3

Research Sites

65 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating the balance between excitatory and inhibitory brain activity as a possible molecular mechanism in schizophrenia. This study evaluates various brain activity markers using fMRI and EEG in patients with schizophrenia, their healthy relatives, and unrelated healthy controls. The goal is to understand the genetic basis and reliability of these markers and their relationship to glutamatergic and GABAergic genes and cellular models, which may deepen knowledge of the molecular causes of mental disorders and aid drug development. The study involves 600 participants divided into three groups 200 diagnosed with schizophrenia, 200 healthy relatives, and 200 unrelated healthy controls. Participants undergo blood tests, genetic analysis, psychiatric and neurological assessments, and brain imaging including EEG and MRI scans using specific stimuli. Some participants may have repeated measurements within three years. A subset of participants will provide additional blood samples to generate stem cells for further research. Participants will spend approximately five hours undergoing various tests on the same day or over up to three weeks. The study collects data through psychiatric scales, neuropsychological tests, EEG and MRI recordings, and blood analyses. Follow-up measurements may occur between one day and three years later. The primary outcomes measured are auditory mismatch negativity and auditory steady state response power, with multiple secondary assessments including functional connectivity, psychopathology, and neuropsychological status.

CONDITIONS

Brief Title

Translational Investigation of the Glutamatergic and GABAergic System in Schizophrenia

Research Team

A

Arnim Gaebler, M.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here